Additionally, pancreatic cancer progression could also be restrained by other types of engineered exosomes, such as PCCs-derived Exosomes loading with short interfering RNA against P21-activated kinase 4 (PAK4) [165], and BM-MSCs loading with miR-1231 [166]. This evidence concerns the gene PAK4 and pancreatic neoplasm.